ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10368	Companies
215967	Keywords
145708	Articles
114374	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/22/2025 at 22:05, 1 year ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle pour le 6 juin 2025 à Paris, alors que la Société se rapproche d'étapes clés en 2025

Biotechnologie Abivax Assemblée Générale Annuelle Phase 3 Mécanismes De Régulation
PRESS RELEASE

published on 04/22/2025 at 22:05, 1 year ago

Abivax annonce les modalités de son Assemblée Générale Annuelle alors que la Société se rapproche d’étapes clés créatrices de valeur en 2025
Abivax annonce les modalités de son Assemblée Générale Annuelle et se rapproche d'étapes clés créatrices de valeur en 2025. Essais cliniques ABTECT de phase 3 en progression

Abivax Étapes Clés Assemblée Générale Annuelle Phase 3 ABTECT
BRIEF

published on 04/22/2025 at 22:05, 1 year ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
BRIEF

published on 04/22/2025 at 22:05, 1 year ago

Abivax accueille le Dr Dominik Höchli au sein de son Conseil d’administration

Abivax Conseil D'administration Phase 3 Immunologie Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:05, 1 year ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 year ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax nomme le Dr Dominik Höchli au Conseil d’administration pour renforcer son expertise en immunologie avant la publication des données clés de l’étude de phase 3 dans la rectocolite hémorragique en 2025

Abivax Conseil D'administration Rectocolite Hémorragique Immunologie Dr Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 year ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3

Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE

published on 04/22/2025 at 22:00, 1 year ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF

published on 04/18/2025 at 18:05, 1 year ago

ABIVAX: Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 1 year ago

ABIVAX : Capital Social et Droits de Vote au 31 Mars 2025

Euronext Paris Droits De Vote Capital Social Actions Abivax

Accesswire

Published on 05/08/2026 at 00:45, 48 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 1 hour 33 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 2 hours 3 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 2 hours 18 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 3 hours 28 minutes ago

MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 2 hours 9 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 2 hours 19 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 3 hours 28 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 4 hours 51 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 6 hours 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 6 hours 18 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 6 hours 18 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 6 hours 27 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 6 hours 27 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 6 hours 33 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE